Skip to content

The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section

The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06102382
Enrollment
100
Registered
2023-10-26
Start date
2024-09-01
Completion date
2025-12-01
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Hypotension, Norepinephrine

Keywords

Norepinephrine, Spinal anesthesia, Hypotension, Cesarean section

Brief summary

To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.

Detailed description

Hypotension after spinal anesthesia for cesarean delivery is common and is caused mainly by peripheral vasodilatation. Although the intravenous administration of fluids helps, it does not always prevent maternal hypotension. Usually, this hypotension is treated with phenylephrine or ephedrine. Norepinephrine has been recently introduced for prophylaxis against post-spinal hypotension during cesarean delivery due to its α-adrenergic activity in addition to the weak β-adrenergic activity. Although the use of norepinephrine for this purpose has shown promising results. However, no sufficient data are available with regard to its optimum dose. The objective of this study is to compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.

Interventions

DRUGNorepinephrine (0.1)

An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.1 µg/kg/min till 5 minutes after delivery of the fetus.

DRUGNorepinephrine (0.075)

An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.075 µg/kg/min till 5 minutes after delivery of the fetus.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women scheduled for cesarean section under spinal anesthesia * Gestational age of at least 37 weeks

Exclusion criteria

* Patient refusal * Contraindications of spinal anesthesia * Allergy to the study drug * Height\<150 cm, weight \< 60 kg, body mass index (BMI) ≥40 kg/m2. * patients with cardiac morbidities * Hypertensive disorders of pregnancy. * Prepartum hemorrhage

Design outcomes

Primary

MeasureTime frame
The frequency of post-spinal hypotensionDuring the first hour after the subarachnoid block

Secondary

MeasureTime frameDescription
Arterial blood pressure (Systolic, diastolic, and mean)During the first hour after the subarachnoid block
Heart rateDuring the first hour after the subarachnoid block
Doses of atropine and ephedrineIntraoperative
Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score1, 5, and 10 minutes after deliveryRanges from 0 (the worst score) to 10 (the best score)

Countries

Egypt

Contacts

Primary ContactZakaria A. Zakaria
za6841924@gmail.com+201150637566

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026